EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance

Ting Li, Lianshan Guo iD, Jiaxu Li iD, Xingyu Mu, Lijuan Liu iD, Shulin Song, Ningbin Luo, Qi Zhang iD, Bin Zheng, Guanqiao Jin

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s445879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Ting Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People's Republic of China. Hauptthemen laut MEDLINE: Magnetite Nanoparticles, Neoplasms, Dextrans. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetite NanoparticlesNeoplasmsDextransHumansPhotothermal TherapySialyl Lewis X AntigenImmune Checkpoint InhibitorsTheranostic NanomedicineImmunotherapyTumor MicroenvironmentB7-H1 AntigenCell Line, Tumor

Stichwörter der Autor:innen

enhancing efficacyimmune checkpoint blockadeimmunotherapy resistancenanotheranostic agentphotothermal therapy

Substanzen

ferumoxtran-10Sialyl Lewis X AntigenImmune Checkpoint InhibitorsMagnetite NanoparticlesB7-H1 AntigenDextrans

Autor:innen und Institutionen

  • Department of Radiology, Guangxi Medical University Cancer Hospital, Nanning, 530021, People's Republic of China.
  • Department of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, People's Republic of China.
  • Guangxi Key Laboratory of Natural Polymer Chemistry and Physics, College of Chemistry and Materials, Graduate School, Nanning Normal University, Nanning, 530001, People's Republic of China.
  • Department of Nuclear Medicine, Affiliated Hospital of Guilin Medical University, Guilin, 541001, People's Republic of China.
  • Laboratory Animal Center, Guangxi Medical University, Nanning, 530021, People's Republic of China.

ORCID-Profile: Lianshan Guo, Jiaxu Li, Lijuan Liu, Qi Zhang

Zitieren

APA

Li, T., Guo, L., Li, J., Mu, X., Liu, L., Song, S., Luo, N., Zhang, Q., Zheng, B., & Jin, G. (2024). Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s445879

Vancouver

Li T, Guo L, Li J, Mu X, Liu L, Song S, et al. Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s445879

BibTeX
@article{Li2024,
  author = {Li, Ting and Guo, Lianshan and Li, Jiaxu and Mu, Xingyu and Liu, Lijuan and Song, Shulin and Luo, Ningbin and Zhang, Qi and Zheng, Bin and Jin, Guanqiao},
  title = {Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s445879}
}
Kostenlos starten →